Pilot Clinical Trial of an Integrative Intervention to Improve Critically Ill Patients' Delirium and Related Outcomes
REPOSE
Relaxation for Critically Ill Patient Outcomes and Stress-coping Enhancement (REPOSE 1.0): Pilot Clinical Trial of an Integrative Intervention to Improve Critically Ill Patients' Delirium and Related Outcomes
1 other identifier
interventional
27
1 country
1
Brief Summary
Methodology: Pilot randomized controlled trial with 1 intervention and 1 parallel standard care group to assess the feasibility and treatment effect of a multimodal integrative intervention for delirium prevention and associated detrimental effects. Duration: 2 years, two months. Study Center(s): Multi-center (2 sites) Aim: To assess feasibility and measures of effect of a multimodal intervention consisting of relaxation with guided imagery (RGI), and moderate pressure massage on physiological and psychological outcomes of critically ill patients. Objectives: a) assess clinical trial feasibility with pre-defined goals (enrollment, randomization, adherence, timing of intervention, workload), b) calculate estimates and variance of treatment effect across outcome measures, c) calculate confidence intervals (CI) of incidence proportions, means and standard deviation (SD) of outcome measures in study groups., d) explore underlying physiological mechanisms of efficacy Number of Subjects: 60 participants per arm. Total: 120 participants Diagnosis and Main Inclusion Criteria: Critical illness Inclusion criteria: a) Age over 18 years, b) ICDSC:0-3. Exclusion Criteria: Patients: a) with expected ICU LOS\< 72 hours, b) with acute neurological illness/ trauma, persistent sedation or coma, c) with current history of severe mental health problems and dementia, as per history and psychiatrist assessment, c) with hearing impairment or conditions not permitting use of headphones, e) on neuro-muscular blockers, f) with substance/ alcohol withdrawal, g) enrolled in trials of sedatives, antipsychotics. Intervention: REPOSE intervention (a multimodal relaxation intervention) It includes: a) relaxation and guided imagery (RGI) (40 min, headphones), b) a brief moderate pressure massage session (massage: 15 min). RGI involves: a) guided relaxation, b) a structured guided imagery script and c) music for 15 min (Mozart piano sonata KV283, G major (2 3) II Andante). Duration of administration: Up to 5 days while participants still in the ICU. Reference therapy: Standard care plus placebo to maintain blinding. Statistical Methodology: Outcomes will be analyzed longitudinally over 5 days by logistic regression model based on generalized estimating equations (GEE) with AR(1) correlation structure. Confidence intervals will be presented with estimated effects. Primary analysis will be based on all available data utilizing data from all assessments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 22, 2016
CompletedFirst Posted
Study publicly available on registry
September 19, 2016
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2027
May 11, 2026
May 1, 2026
8.3 years
August 22, 2016
May 5, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility 1: Recruitment rate (percentage of patients recruited among eligible patients)
recruitment rate (percentage of patients recruited among eligible patients)
up to 2 years
Secondary Outcomes (20)
Eligibility (percentage (%) of eligible patients among patients screened)
up to 2 years
Enrollment [Time (min) from admission to enrollment]
up to 2 years
Reasons for delayed enrollment (content analysis categories & descriptive statistics of free-text entries describing reasons for delay)
up to 2 years
Non-Consent (Percentage of eligible patients declining consent)
up to 2 years
Protocol completion (Percentage of participants completing the entire study protocol)
Up to 25 months
- +15 more secondary outcomes
Other Outcomes (23)
NRS Pain intensity [self-reported (S-R) Numeric Rating Scale (NRS)]
Up to 30 days (Pre- & post- intervention during first 5 days)
Pain ratings [Critical Care Pain Observation Tool (CPOT)]
Up to 30 days (Pre- & post- intervention during first 5 days)
Pain distress (self-reported (S-R) numeric rating scale (NRS)
Up to 30 days (Pre- & post- intervention during first 5 days)
- +20 more other outcomes
Study Arms (2)
RGI & Massage
ACTIVE COMPARATOR1. relaxation and guided imagery with background music (RGI) (40 min, headphones) 2. a brief moderate pressure massage session (massage: 15 min)
Control
NO INTERVENTIONSham intervention: Silent headphones to mask the audio component, and presence of an intervention nurse at the bedside with drawn curtains.
Interventions
A trained intervention nurse will administer a 15 min moderate pressure massage as well as guided imagery with music once daily for up to five consecutive days.
Eligibility Criteria
You may qualify if:
- patients hospitalized in one of the study Intensive Care Units (ICUs)
- Age over 18 years
- Intensive Care Delirium Screening Checklist (ICDSC):0-3
- patients enrolled in other investigative trials not involving sedative, psychoactive medications
You may not qualify if:
- patients with expected Intensive Care Unit length of stay \< 72 hours
- patients with acute neurological illness/ trauma, persistent sedation or coma
- patients with current history of severe mental health problems and dementia, as per history and psychiatrist assessment
- patients with hearing impairment or conditions not permitting use of headphones
- patients on neuro-muscular blocker medications
- patients with substance/ alcohol withdrawal
- patients enrolled in trials of sedatives, antipsychotics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Albertalead
- Royal Alexandra Hospitalcollaborator
Study Sites (1)
Misreicordia Hospital
Edmonton, Alberta, T5R 4H5, Canada
Related Publications (1)
Papathanassoglou EDE, Skrobik Y, Hegadoren K, Thompson P, Stelfox HT, Norris C, Rose L, Bagshaw SM, Meier M, LoCicero C, Ashmore R, Sparrow Brulotte T, Hassan I, Park T, Kutsogiannis DJ. Relaxation for Critically ill Patient Outcomes and Stress-coping Enhancement (REPOSE): a protocol for a pilot randomised trial of an integrative intervention to improve critically ill patients' delirium and related outcomes. BMJ Open. 2019 Jan 15;9(1):e023961. doi: 10.1136/bmjopen-2018-023961.
PMID: 30782719DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elisavet Papathanasoglou, PhD
University of Alberta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2016
First Posted
September 19, 2016
Study Start
March 1, 2019
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
May 31, 2027
Last Updated
May 11, 2026
Record last verified: 2026-05